Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study

Kamalakar Vasant Gajare; Vijay Ukhalkar; Suresh Podhade; Santosh Pathak; Sasibhushan Vedula; Rajiva Kumar Rai; Sastry JLN

doi:10.5455/jrtm.2022/125819

J. res. tradit. med. 2022; 8(1, Jan- June 2022): 3-12

doi: 10.5455/jrtm.2022/125819

Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study

Kamalakar Vasant Gajare, Vijay Ukhalkar, Suresh Podhade, Santosh Pathak, Sasibhushan Vedula, Rajiva Kumar Rai, Sastry JLN.

Abstract
Background: The pathogenesis and treatment of Ashmari (Urolithiasis) are well explained in Ayurveda texts. While various herbal remedies are used for the medical management of Urolithiasis, very few have been studied clinically for safety and efficacy.

Objective: To evaluate the safety and efficacy of Stondab tablet in reducing the size and expelling of urinary calculi and in relieving the symptoms of calculi.

Materials and Methods: The study was conducted in a Randomized, Active Controlled, Open Labelled, Multi-centric design with 108 subjects completing the study. Subjects were given either test product or comparator as per randomization, two tablets, thrice daily for the period of 90 days to be taken with water. Subjects were followed up every 15 days for 90 days for clinical and laboratory assessment as planned.

Results: Subjects in the Stondab group showed an expulsion rate of calculi (5-12 mm) of 49.23% and 66.66% (less than 5 mm) at the end of 90 days. There was a reduction in clinical symptoms like pain in the abdomen, burning micturition, hematuria, painful micturition, frequency of micturition, and the number of episodes of pain in the Stondab group and which was comparable with the comparator group. The study product was found to be safe and well-tolerated.

Conclusion: It may be concluded that Stondab is safe and effective in the management of renal calculi. It also helped in the reduction of clinical symptoms of renal calculi as well as there is a clinically significant effect on new stone formation.

Key words: Abdominal pain, Expulsion rate, Renal Calculi, Stondab, Urolithiasis.

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Kamalakar Vasant Gajare Articles by Vijay Ukhalkar Articles by Suresh Podhade Articles by Santosh Pathak Articles by Sasibhushan Vedula Articles by Rajiva Kumar Rai Articles by Sastry JLN
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Gajare KV, Ukhalkar V, Podhade S, Pathak S, Vedula S, Rai RK, JLN S. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. J. res. tradit. med. 2022; 8(1, Jan- June 2022): 3-12. doi:10.5455/jrtm.2022/125819

Web Style

Gajare KV, Ukhalkar V, Podhade S, Pathak S, Vedula S, Rai RK, JLN S. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. https://www.tmjournal.org/?mno=125819 [Access: September 13, 2024]. doi:10.5455/jrtm.2022/125819

AMA (American Medical Association) Style

Gajare KV, Ukhalkar V, Podhade S, Pathak S, Vedula S, Rai RK, JLN S. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. J. res. tradit. med. 2022; 8(1, Jan- June 2022): 3-12. doi:10.5455/jrtm.2022/125819

Vancouver/ICMJE Style

Gajare KV, Ukhalkar V, Podhade S, Pathak S, Vedula S, Rai RK, JLN S. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. J. res. tradit. med. (2022), [cited September 13, 2024]; 8(1, Jan- June 2022): 3-12. doi:10.5455/jrtm.2022/125819

Harvard Style

Gajare, K. V., Ukhalkar, . V., Podhade, . S., Pathak, . S., Vedula, . S., Rai, . R. K. & JLN, . S. (2022) Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. J. res. tradit. med, 8 (1, Jan- June 2022), 3-12. doi:10.5455/jrtm.2022/125819

Turabian Style

Gajare, Kamalakar Vasant, Vijay Ukhalkar, Suresh Podhade, Santosh Pathak, Sasibhushan Vedula, Rajiva Kumar Rai, and Sastry JLN. 2022. Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE, 8 (1, Jan- June 2022), 3-12. doi:10.5455/jrtm.2022/125819

Chicago Style

Gajare, Kamalakar Vasant, Vijay Ukhalkar, Suresh Podhade, Santosh Pathak, Sasibhushan Vedula, Rajiva Kumar Rai, and Sastry JLN. "Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 8 (2022), 3-12. doi:10.5455/jrtm.2022/125819

MLA (The Modern Language Association) Style

Gajare, Kamalakar Vasant, Vijay Ukhalkar, Suresh Podhade, Santosh Pathak, Sasibhushan Vedula, Rajiva Kumar Rai, and Sastry JLN. "Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 8.1, Jan- June 2022 (2022), 3-12. Print. doi:10.5455/jrtm.2022/125819

APA (American Psychological Association) Style

Gajare, K. V., Ukhalkar, . V., Podhade, . S., Pathak, . S., Vedula, . S., Rai, . R. K. & JLN, . S. (2022) Evaluation of safety and efficacy of Stondab tablets in the management of Urinary Calculi: An open label, randomized, multi-center, prospective, comparative clinical study. JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE, 8 (1, Jan- June 2022), 3-12. doi:10.5455/jrtm.2022/125819